Patents by Inventor Ramin Farzaneh-Far

Ramin Farzaneh-Far has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating anemia
    Patent number: 11844756
    Abstract: Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.
    Type: Grant
    Filed: April 4, 2022
    Date of Patent: December 19, 2023
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Alexander Smith, Gurudatt Ajay Chandorkar, Ene Ikpong Ette, Bradley John Maroni, Charlotte Suzanne Hartman, Ramin Farzaneh-Far, Jula Kern Inrig
  • Modulators of complement activity
    Patent number: 11723949
    Abstract: The present disclosure relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics. Also provided are methods of measuring C5 and related complexes using C5 binding agents.
    Type: Grant
    Filed: August 12, 2021
    Date of Patent: August 15, 2023
    Assignee: Ra Pharmaceuticals, Inc.
    Inventors: Alonso Ricardo, Steven James DeMarco, Sylvia Tobe, Michelle Denise Hoarty, Robert Paul Hammer, Douglas A. Treco, Kathleen Seyb, Vaishnavi Rajagopal, Guo-Qing Tang, Douangsone D. Vadysirisack, Ramin Farzaneh-Far
  • Compositions and Methods for Treating Anemia
    Publication number: 20230071553
    Abstract: Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.
    Type: Application
    Filed: April 4, 2022
    Publication date: March 9, 2023
    Inventors: Alexander Smith, Gurudatt Ajay Chandorkar, Ene Ikpong Ette, Bradley John Maroni, Charlotte Suzanne Hartman, Ramin Farzaneh-Far, Jula Kern Inrig
  • INFLAMMATORY DISEASE TREATMENT WITH COMPLEMENT INHIBITORS
    Publication number: 20220257697
    Abstract: The present disclosure provides methods of treating inflammatory indications with complement inhibitor compounds and compositions. Included are compounds and methods of treating neuromuscular inflammatory indications, such as Immune-Mediated Necrotizing Myopathy.
    Type: Application
    Filed: June 4, 2020
    Publication date: August 18, 2022
    Inventors: Petra DUDA, Ramin FARZANEH-FAR, Alonso RICARDO, Camil SAYEGH, Nanqun ZHU, Douangsone D. VADYSIRISACK, Olivier BOYER, Laurent DROUOT
  • MODULATORS OF COMPLEMENT ACTIVITY
    Publication number: 20220233632
    Abstract: The present disclosure relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics. Also provided are methods of measuring C5 and related complexes using C5 binding agents.
    Type: Application
    Filed: August 12, 2021
    Publication date: July 28, 2022
    Inventors: Alonso Ricardo, Steven James DeMarco, Sylvia Tobe, Michelle Denise Hoarty, Robert Paul Hammer, Douglas A. Treco, Kathleen Seyb, Vaishnavi Rajagopal, Guo-Qing Tang, Douangsone D. Vadysirisack, Ramin Farzaneh-Far
  • MODULATORS OF COMPLEMENT ACTIVITY
    Publication number: 20220160820
    Abstract: The present disclosure provides compounds, compositions, and methods for modulating complement activity. Included are C5 inhibitor compounds and related methods of use in treating complement-related indications.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 26, 2022
    Inventors: Zhong Ma, Nanqun Zhu, Evan Thackaberry, Ramin Farzaneh-Far, Alonso Ricardo
  • Compositions and methods for treating anemia
    Patent number: 11324734
    Abstract: Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: May 10, 2022
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Alexander Smith, Gurudatt Ajay Chandorkar, Ene Ikpong Ette, Bradley John Maroni, Charlotte Suzanne Hartman, Ramin Farzaneh-Far, Jula Kern Inrig
  • NEUROLOGICAL DISEASE TREATMENT WITH ZILUCOPLAN
    Publication number: 20220133841
    Abstract: Embodiments of the present disclosure include methods of treating myasthenia gravis, including generalized myasthenia gravis, by providing C5 complement inhibitors. Included are devices and kits for inhibitor administration and methods of evaluating complement inhibitor treatment efficacy.
    Type: Application
    Filed: October 22, 2019
    Publication date: May 5, 2022
    Inventors: Petra Duda, Ramin Farzaneh-Far, Zhong Ma, Nanqun Zhu, Evan Thackaberry, Alonso Ricardo
  • Modulators of complement activity
    Patent number: 11123399
    Abstract: The present disclosure relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics. Also provided are methods of measuring C5 and related complexes using C5 binding agents.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: September 21, 2021
    Assignee: RA PHARMACEUTICALS, INC.
    Inventors: Alonso Ricardo, Steven James DeMarco, Sylvia Tobe, Michelle Denise Hoarty, Robert Paul Hammer, Douglas A. Treco, Kathleen Seyb, Vaishnavi Rajagopal, Guo-Qing Tang, Douangsone D. Vadysirisack, Ramin Farzaneh-Far
  • MODULATORS OF COMPLEMENT ACTIVITY
    Publication number: 20210000927
    Abstract: The present disclosure provides methods of treating paroxysmal nocturnal hemoglobinuria (PNH) in subjects with varying exposure to eculizumab by administering R5000. The methods include methods of switching subjects from treatment with eculizumab to R5000.
    Type: Application
    Filed: December 4, 2018
    Publication date: January 7, 2021
    Inventors: Alonso Ricardo, Michelle Denise Hoarty, Ramin Farzaneh-Far
  • MODULATORS OF COMPLEMENT ACTIVITY
    Publication number: 20200038477
    Abstract: The present disclosure relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics. Also provided are methods of measuring C5 and related complexes using C5 binding agents.
    Type: Application
    Filed: December 7, 2017
    Publication date: February 6, 2020
    Inventors: Alonso Ricardo, Steven James DeMarco, Sylvia Tobe, Michelle Denise Hoarty, Robert Paul Hammer, Douglas A. Treco, Kathleen Seyb, Vaishnavi Rajagopal, Guo-Qing Tang, Douangsone D. Vadysirisack, Ramin Farzaneh-Far
  • Compositions and Methods for Treating Anemia
    Publication number: 20180092892
    Abstract: Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.
    Type: Application
    Filed: March 31, 2016
    Publication date: April 5, 2018
    Applicant: Akebia Therapeutics, Inc.
    Inventors: Alexander Smith, Gurudatt Ajay Chandorkar, Ene Ikpong Ette, Bradley John Maroni, Charlotte Suzanne Hartman, Ramin Farzaneh-Far, Jula Kem Inrig
  • Methods of treating hypertrophic cardiomyopathy
    Patent number: 9125916
    Abstract: The present disclosure relates to a compound of formula (I) or formula (II) or a pharmaceutically acceptable salt thereof, for use in the treatment of hypertrophic cardiomyopathy.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: September 8, 2015
    Assignee: Gilead Sciences, Inc.
    Inventors: Luiz Belardinelli, Ramin Farzaneh-Far
  • METHODS OF TREATING HYPERTROPHIC CARDIOMYOPATHY
    Publication number: 20150038487
    Abstract: The present disclosure relates to a compound of formula (I) or formula (II) or a pharmaceutically acceptable salt thereof, for use in the treatment of hypertrophic cardiomyopathy.
    Type: Application
    Filed: July 28, 2014
    Publication date: February 5, 2015
    Inventors: Luiz Belardinelli, Ramin Farzaneh-Far